(Q37103073)

English

Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma

scientific article published on 05 January 2009

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

1 reference

based on heuristic

inferred from title

author name string

Sujata Chakraborty

1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Can-Lan Sun

2

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Liton Francisco

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Melanie Sabado

4

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Liang Li

5

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Karen L Chang

6

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Stephen Forman

7

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Smita Bhatia

8

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Ravi Bhatia

9

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

language of work or name

0 references

publication date

5 January 2009

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

27

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

791-798

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

describes a project that uses

1 reference

Europe PubMed Central

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC2645091/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

Telomeres, stem cells, and hematology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

14 September 2017

Telomere maintenance and human bone marrow failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

14 September 2017

Identification and functional characterization of novel telomerase variant alleles in Japanese patients with bone-marrow failure syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

14 September 2017

Short telomeres limit tumor progression in vivo by inducing senescence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

14 September 2017

Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

14 September 2017

Telomere length dynamics in normal hematopoiesis and in disease states characterized by increased stem cell turnover

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

14 September 2017

Telomere-related genome instability in cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

14 September 2017

Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

14 September 2017

Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

14 September 2017

Functional characterization of telomerase RNA variants found in patients with hematologic disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

14 September 2017

Stem cells, telomerase and dyskeratosis congenita

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

14 September 2017

SYBR Green real-time telomeric repeat amplification protocol for the rapid quantification of telomerase activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

14 September 2017

Simultaneous flow cytometric analysis of two cell surface markers, telomere length, and DNA content

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

14 September 2017

Telomere dynamics in myelodysplastic syndromes and acute leukemic transformation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

14 September 2017

Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

14 September 2017

High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

14 September 2017

Telomere analysis by fluorescence in situ hybridization and flow cytometry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

14 September 2017

Telomeres shorten during ageing of human fibroblasts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

14 September 2017

Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

14 September 2017

Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

29 September 2017

Malignant neoplasms following bone marrow transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

29 September 2017

Incidence of second cancers in patients treated for Hodgkin's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

29 September 2017

A human neoplastic hematopoietic cell line producing a fibroblast type of interferon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

29 September 2017

Long-term follow-up of recipients of allogeneic bone marrow grafts reveals no progressive telomere shortening and provides no evidence for haematopoietic stem cell exhaustion.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

27 June 2018

Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

27 June 2018

Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

27 June 2018

Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. Association of the Nordic Cancer Registries and the Nordic Society of

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

27 June 2018

Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

27 June 2018

Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

27 June 2018

Second acute leukemia and other malignancies following treatment for Hodgkin's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

27 June 2018

Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

27 June 2018

Leukemia following chemotherapy for ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

27 June 2018

Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

27 June 2018

Progressive telomere shortening in aplastic anemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

27 July 2018

Sustained telomere erosion due to increased stem cell turnover during triple autologous hematopoietic stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

3 September 2018

Genetic variation in telomeric repeat binding factors 1 and 2 in aplastic anemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

3 September 2018

Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

3 September 2018

Telomere length shortening in non-Hodgkin's lymphoma patients undergoing chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

3 September 2018

Telomere dysfunction and the initiation of genome instability.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

3 September 2018

Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

3 September 2018

Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

3 September 2018

Second cancers among long-term survivors of non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

3 September 2018

Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

3 September 2018

Outcome in Patients With Myelodysplastic Syndrome After Autologous Bone Marrow Transplantation for Non-Hodgkin's Lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645091

4 December 2018

Risk of leukemia after chemotherapy and radiation treatment for breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19124806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19124806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/19124806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Telomerase activity in normal leukocytes and in hematologic malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/19124806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preceding standard therapy is the likely cause of MDS after autotransplants for multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19124806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accelerated telomere shortening in bone-marrow recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19124806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes of telomere length in children after hematopoietic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19124806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Telomere shortening in recipients of bone-marrow transplants

1 reference

https://pubmed.ncbi.nlm.nih.gov/19124806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19124806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19124806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acceleration of telomere loss by chemotherapy is greater in older patients with locally advanced head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19124806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term lymphoma survivors following high-dose chemotherapy and autograft: evidence of permanent telomere shortening in myeloid cells, associated with marked reduction of bone marrow hematopoietic stem cell reservoir

1 reference

https://pubmed.ncbi.nlm.nih.gov/19124806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Limited telomere shortening in hematopoietic stem cells after transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19124806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flow cytometric determination of telomere length

1 reference

https://pubmed.ncbi.nlm.nih.gov/19124806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accelerated telomere length shortening in granulocytes: a diagnostic marker for myeloproliferative diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/19124806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19124806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of second cancers after treatment for Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19124806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2008.17.1033

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37103073&oldid=2149990758"